Home > Boards > US Listed > Medical - Drugs > Cancer Genetics Inc. (CGIX)

the vote is Oct 10 to approve the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sindram Member Profile
 
Followed By 1
Posts 460
Boards Moderated 0
Alias Born 02/05/05
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/2/2020 3:57:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 8:00:55 AM
Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire Inc. - 11/20/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/19/2019 5:31:08 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2019 4:13:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2019 4:11:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/25/2019 8:01:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/25/2019 6:05:24 AM
Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire Inc. - 10/24/2019 4:15:05 PM
Cancer Genetics Announces 1-for-30 Reverse Stock Split GlobeNewswire Inc. - 10/24/2019 8:30:05 AM
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners GlobeNewswire Inc. - 10/17/2019 6:55:05 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 5:29:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2019 8:42:24 AM
Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire Inc. - 8/20/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2019 5:28:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:19:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:16:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:14:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:10:03 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2019 4:06:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 4:06:35 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/25/2019 8:01:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 5:30:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 5:23:45 PM
Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire Inc. - 7/15/2019 4:22:03 PM
sindram   Friday, 10/04/19 05:22:47 PM
Re: None
Post # of 875 
the vote is Oct 10 to approve the 7.7 million $ next week this runs $

"Under the terms of the acquisition agreement, Interpace purchased the BioPharma Business pursuant to a Uniform Commercial Code Article 9 transaction whereby secured creditors were paid off and Interpace made an additional payment of approximately $4.5 million to Cancer Genetics, using proceeds from the initial financing provided by Ampersand. In addition, Interpace issued Cancer Genetics a $7.7 million 6% interest bearing note due upon the earlier of Interpace’s shareholder approval and Ampersand’s second tranche investment or three years."

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist